Brief: Uni-Bio Science Group Updates On Development Of Anti-Diabetic Acarbose Oral Tablet
04/01/2019 15:07
Jan 4 (Reuters) - Uni-Bio Science Group Ltd 0690.HK :
* UPDATES ON DEVELOPMENT OF ANTI-DIABETIC ACARBOSE ORAL
TABLET
* ACARBOSE TABLETS JOINTLY DEVELOPED BY UNIT & BEIJING BAIAO
PHARMACEUTICAL HAS BEEN FORMALLY ACCEPTED BY CHINA FDA
Source text for Eikon: ID:nHKS9QvcZq
Further company coverage: 0690.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsBrief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA
Brief: Uni-Bio Science Group Says Marketing Application Of Diquafosol Sodium Eye Drops Officially Approved By NMPA
Brief: Uni-Bio Science Declares Final Dividend Of Hk0.277 Cents Per Share